You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AKTX Award Disclosure
Bazemore Robert B · SEC Form 4 · Filed Oct 16, 2026
Award
Calculated transaction value
$0
Bazemore Robert B Director
AKTX
Transaction date
Aug 18, 2026
Public filing date
Oct 16, 2026
Filing lag
Filed 59 days later
AKTX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on American Depositary Shares representing Ordinary Shares
- Quantity / price
- 45,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001493152-26-047455
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$202.9K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Akari Therapeutics Plc AKTX | Exercise | Oct 14, 2026 | $0.31 |
| Akari Therapeutics Plc AKTX | Exercise | Oct 14, 2026 | $1.24 |
| Akari Therapeutics Plc AKTX | Exercise | Oct 14, 2026 | $49.98K |
| Akari Therapeutics Plc AKTX | Exercise | Oct 14, 2026 | $12.49K |
| Akari Therapeutics Plc AKTX | Award | Oct 5, 2026 | $36.94K |
| Akari Therapeutics Plc AKTX Current | Award | Aug 18, 2026 | $0 |
| Akari Therapeutics Plc AKTX | Award | Aug 18, 2026 | $0 |
| Akari Therapeutics Plc AKTX | Award | Aug 18, 2026 | $103.48K |